| LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
IL12RB2 |
IL12RB2: Interleukin-12 receptor beta-2 chain precursor |
0.307 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
0.307 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.307 |
Evidence |
|
| IL1B |
IL1B, IL1F2: Interleukin-1 beta precursor |
IL1RL1 |
IL1RL1, DER4, ST2, T1: Interleukin-1 receptor-like 1 precursor |
0.307 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
0.307 |
Evidence |
|
| OR10H3 |
OR10H3: Olfactory receptor 10H3 |
CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
0.307 |
Evidence |
|
| OR10H3 |
OR10H3: Olfactory receptor 10H3 |
IL8 |
IL8: Interleukin-8 precursor |
0.307 |
Evidence |
|
| OR10H3 |
OR10H3: Olfactory receptor 10H3 |
CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
0.307 |
Evidence |
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.307 |
Evidence |
|
| RAB27B |
RAB27B: Ras-related protein Rab-27B |
GDI1 |
GDI1, GDIL, OPHN2, RABGDIA, XAP4: Rab GDP dissociation inhibitor alpha |
0.307 |
Evidence |
|
| CRKRS |
CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 |
C1orf82 |
RPAP2, C1orf82: RNA polymerase II-associated protein 2 |
0.307 |
Evidence |
|
| PCAF |
PCAF: Histone acetyltransferase PCAF |
SUPT16H |
SUPT16H, FACT140, FACTP140: FACT complex subunit SPT16 |
0.307 |
Evidence |
|
| CCNG2 |
CCNG2: Cyclin-G2 |
SUPT16H |
SUPT16H, FACT140, FACTP140: FACT complex subunit SPT16 |
0.307 |
Evidence |
|
| TRIP13 |
TRIP13: Thyroid receptor-interacting protein 13 |
TIPRL |
TIPRL: TIP41-like protein |
0.307 |
Evidence |
|
| GABPA |
GABPA, E4TF1A: GA-binding protein alpha chain |
CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
0.307 |
Evidence |
|
| CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
DVL3 |
DVL3, KIAA0208: Segment polarity protein dishevelled homolog DVL-3 |
0.307 |
Evidence |
|
| RRAS2 |
RRAS2, TC21: Ras-related protein R-Ras2 precursor |
RUNX3 |
IPI00218386 |
0.307 |
Evidence |
|
| EIF1AX |
EIF1AX, EIF1A, EIF4C: Eukaryotic translation initiation factor 1A, X-chromosomal |
EIF2B4 |
IPI00220232 |
0.307 |
Evidence |
|
| PPP1R2 |
PPP1R2, IPP2: Protein phosphatase inhibitor 2 |
CFDP1 |
CFDP1, BCNT: Craniofacial development protein 1 |
0.307 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
RUNX3 |
IPI00218386 |
0.307 |
Evidence |
|
| APC |
IPI00215877 |
TIPRL |
TIPRL: TIP41-like protein |
0.307 |
Evidence |
|
| CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
0.307 |
Evidence |
|
| POLB |
POLB: DNA polymerase beta |
MSH2 |
MSH2: DNA mismatch repair protein Msh2 |
0.307 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CDC37 |
CDC37: Hsp90 co-chaperone Cdc37 |
0.307 |
Evidence |
|